Connecticut Employers Limit GLP-1 Weight Loss Drug Costs As GLP-1 weight-loss drug costs surge, most Connecticut employers cover them but impose conditions like prior authorization and lifestyle requirements to manage expenses, a strategy the state employee plan has used to slow spending growth
Su YS, Hu J, Huang ZB, et al
For patients whose cardiac health is at risk, or if it has already been impacted by obesity-related health conditions, semaglutide supports cardiovascular health and can reduce hypertension, sleep apnea and the symptoms of other related diseases
While it can be caused by benign factors like dehydration, it may also indicate more serious health issues requiring medical evaluation
Supplements that claim to shift the pounds and slim our waistlines are understandably attractive, but before you spend, its important to understand the science and whether a particular supplement is appropriate for your circumstances
Use small containers instead of giant meal-prep tubs